Concomitant Sparsentan and Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Patients with IgA Nephropathy (IgAN) in the PROTECT Open-Label Extension (OLE)

The requested reference [03c942e7a69d0353fc76157f85409a568e2ed752] no longer exists in our database. It has been replaced by the current reference: [693f2889cb25ed50011dc28866a7264d74651344]

Authors
Category Primary study
JournalJournal of the American Society of Nephrology : JASN
Year 2023
This article has no abstract
Epistemonikos ID: 5b2c1fa206864dff52b6f4f3f8e143de0c2b95f8
First added on: Dec 07, 2023